Premium
Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg‐interferon and ribavirin in a patient co‐infected with HIV
Author(s) -
Rachline Anne,
Palmer Pierre,
Simon François,
Molina JeanMichel
Publication year - 2010
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.21781
Subject(s) - ribavirin , medicine , virology , hepatitis c virus , virus , adverse effect , chronic hepatitis , human immunodeficiency virus (hiv) , viral disease , interferon , pegylated interferon , alpha interferon , immunology
The recommended treatment duration of chronic hepatitis C virus (HCV) in patients infected with human immunodeficiency virus (HIV) is 48 weeks. This report describes a patient co‐infected with HCV genotype 2 and HIV who discontinued HCV therapy after 6 weeks because of adverse events and had a sustained virologic response. J. Med. Virol. 82:1150–1151, 2010. © 2010 Wiley‐Liss, Inc.